Lv6
2780 积分 2023-04-17 加入
573P M9140, an anti-CEACAM5 antibody drug conjugate (ADC), in patients with metastatic colorectal cancer (mCRC): Updated results from a phase I trial
6小时前
待确认
Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial
1天前
待确认
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
1个月前
已完结
药物过敏诊断和预防方案中国专家共识【2022】
4个月前
已完结
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma
4个月前
已完结
Endometriosis Typology and Ovarian Cancer Risk
7个月前
已完结
First cell therapy for solid tumours heads to the clinic: what it means for cancer treatment
1年前
已完结
Comprehensive single institute experience with melanoma TIL: Long term clinical results, toxicity profile, and prognostic factors of response
1年前
已完结
Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy
1年前
已完结
皖公网安备34019202002308
